Feedback control of ErbB2 via ERK-mediated phosphorylation of a conserved threonine in the juxtamembrane domain

Tyrosine kinase activity of the asymmetric EGFR homodimer is negatively regulated via ERK-mediated phosphorylation of Thr-669 in the juxtamembrane domain. In the present study, we investigated in human breast cancer cells whether a similar mechanism plays a role in the feedback regulation of the Erb...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 6; no. 1; p. 31502
Main Authors Kawasaki, Yuki, Sakimura, Ayaka, Park, Chul Min, Tomaru, Rika, Tanaka, Tomohiro, Ozawa, Tatsuhiko, Zhou, Yue, Narita, Kaori, Kishi, Hiroyuki, Muraguchi, Atsushi, Sakurai, Hiroaki
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 17.08.2016
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Tyrosine kinase activity of the asymmetric EGFR homodimer is negatively regulated via ERK-mediated phosphorylation of Thr-669 in the juxtamembrane domain. In the present study, we investigated in human breast cancer cells whether a similar mechanism plays a role in the feedback regulation of the ErbB2/ErbB3 heterodimer, the most potent ErbB receptor dimer. Constitutive tyrosine phosphorylation of ErbB2 and ErbB3 was significantly decreased in phorbol ester- and growth factor-treated BT-474 and MDA-MB-453 cells. In contrast to the decreased tyrosine phosphorylation, Phos-tag Western blot analysis revealed that TPA induced phosphorylation of ErbB2 in an ERK-dependent manner. The target threonine residue corresponding to EGFR Thr-669 and the surrounding residues are highly conserved in ErbB2, but not in ErbB3. Therefore, we demonstrated ERK-mediated phosphorylation of ErbB2 at Thr-677 by generating phospho-specific monoclonal antibodies. Moreover, treatment with trametinib and SCH772984, inhibitors of the MEK-ERK pathway and substitution of Thr-677 to alanine impaired the feedback inhibition of ErbB2 and ErbB3. These results demonstrated that ERK-mediated phosphorylation of the conserved threonine is a common mechanism for the negative feedback control of active ErbB receptor dimers.
AbstractList Tyrosine kinase activity of the asymmetric EGFR homodimer is negatively regulated via ERK-mediated phosphorylation of Thr-669 in the juxtamembrane domain. In the present study, we investigated in human breast cancer cells whether a similar mechanism plays a role in the feedback regulation of the ErbB2/ErbB3 heterodimer, the most potent ErbB receptor dimer. Constitutive tyrosine phosphorylation of ErbB2 and ErbB3 was significantly decreased in phorbol ester- and growth factor-treated BT-474 and MDA-MB-453 cells. In contrast to the decreased tyrosine phosphorylation, Phos-tag Western blot analysis revealed that TPA induced phosphorylation of ErbB2 in an ERK-dependent manner. The target threonine residue corresponding to EGFR Thr-669 and the surrounding residues are highly conserved in ErbB2, but not in ErbB3. Therefore, we demonstrated ERK-mediated phosphorylation of ErbB2 at Thr-677 by generating phospho-specific monoclonal antibodies. Moreover, treatment with trametinib and SCH772984, inhibitors of the MEK-ERK pathway, and substitution of Thr-677 to alanine impaired the feedback inhibition of ErbB2 and ErbB3. These results demonstrated that ERK-mediated phosphorylation of the conserved threonine is a common mechanism for the negative feedback control of active ErbB receptor dimers.
Abstract Tyrosine kinase activity of the asymmetric EGFR homodimer is negatively regulated via ERK-mediated phosphorylation of Thr-669 in the juxtamembrane domain. In the present study, we investigated in human breast cancer cells whether a similar mechanism plays a role in the feedback regulation of the ErbB2/ErbB3 heterodimer, the most potent ErbB receptor dimer. Constitutive tyrosine phosphorylation of ErbB2 and ErbB3 was significantly decreased in phorbol ester- and growth factor-treated BT-474 and MDA-MB-453 cells. In contrast to the decreased tyrosine phosphorylation, Phos-tag Western blot analysis revealed that TPA induced phosphorylation of ErbB2 in an ERK-dependent manner. The target threonine residue corresponding to EGFR Thr-669 and the surrounding residues are highly conserved in ErbB2, but not in ErbB3. Therefore, we demonstrated ERK-mediated phosphorylation of ErbB2 at Thr-677 by generating phospho-specific monoclonal antibodies. Moreover, treatment with trametinib and SCH772984, inhibitors of the MEK-ERK pathway and substitution of Thr-677 to alanine impaired the feedback inhibition of ErbB2 and ErbB3. These results demonstrated that ERK-mediated phosphorylation of the conserved threonine is a common mechanism for the negative feedback control of active ErbB receptor dimers.
ArticleNumber 31502
Author Ozawa, Tatsuhiko
Kishi, Hiroyuki
Muraguchi, Atsushi
Tomaru, Rika
Narita, Kaori
Sakimura, Ayaka
Sakurai, Hiroaki
Tanaka, Tomohiro
Zhou, Yue
Kawasaki, Yuki
Park, Chul Min
Author_xml – sequence: 1
  givenname: Yuki
  surname: Kawasaki
  fullname: Kawasaki, Yuki
  organization: Department of Cancer Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 2
  givenname: Ayaka
  surname: Sakimura
  fullname: Sakimura, Ayaka
  organization: Department of Cancer Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 3
  givenname: Chul Min
  surname: Park
  fullname: Park, Chul Min
  organization: Department of Cancer Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 4
  givenname: Rika
  surname: Tomaru
  fullname: Tomaru, Rika
  organization: Department of Cancer Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 5
  givenname: Tomohiro
  surname: Tanaka
  fullname: Tanaka, Tomohiro
  organization: Department of Cancer Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 6
  givenname: Tatsuhiko
  surname: Ozawa
  fullname: Ozawa, Tatsuhiko
  organization: Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 7
  givenname: Yue
  surname: Zhou
  fullname: Zhou, Yue
  organization: Department of Cancer Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 8
  givenname: Kaori
  surname: Narita
  fullname: Narita, Kaori
  organization: Department of Cancer Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 9
  givenname: Hiroyuki
  surname: Kishi
  fullname: Kishi, Hiroyuki
  organization: Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 10
  givenname: Atsushi
  surname: Muraguchi
  fullname: Muraguchi, Atsushi
  organization: Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
– sequence: 11
  givenname: Hiroaki
  surname: Sakurai
  fullname: Sakurai, Hiroaki
  organization: Department of Cancer Cell Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27531070$$D View this record in MEDLINE/PubMed
BookMark eNplkV1LHDEUhkOxVKte9A-UAW9sYWo-TeamoLLaUqFQ2uuQZM64WWeSbTKz6L9vltVlq4GQj_PkzXl536O9EAMg9IHgLwQzdZYTLBkRmL5BBxRzUVNG6d7Ofh8d57zAZQjacNK8Q_tUCkawxAcoXgO01rj7ysUwpthXsatmyV7SauVNNfv1ox6g9WaEtlrOYy4zPfZm9DGsSbN-liGtSnmcJ4jBB6h8KAeoFtPDaAYYbDLlso2D8eEIve1Mn-H4aT1Ef65nv6--1bc_b75fXdzWTmA-1spaRYVSoJTkRkrOLSFS8c4QKwhuDRiHuxYUl7LBjjKlsJDMuMYJC5ayQ_R1o7ucbDHgoJgzvV4mP5j0qKPx-v9K8HN9F1eaN0qeU1wETp8EUvw7QR714LODvi9e4pQ1UYQq1XDGC3ryAl3EKYViT5MGM6YIY-eF-rShXIq5hNZtmyFYr5PU2yQL-3G3-y35nFsBPm-AXErhDtLOl6_U_gGVsqoz
CitedBy_id crossref_primary_10_3390_cancers13195004
crossref_primary_10_1155_2023_6726038
crossref_primary_10_18632_oncotarget_20534
crossref_primary_10_3390_molecules26082141
crossref_primary_10_1093_narcan_zcad001
crossref_primary_10_1158_1078_0432_CCR_20_3872
crossref_primary_10_1158_0008_5472_CAN_18_1001
crossref_primary_10_3390_cancers9040027
crossref_primary_10_1016_j_bbrc_2019_04_125
crossref_primary_10_3390_ijms23084258
crossref_primary_10_3390_cancers11030375
crossref_primary_10_1248_yakushi_16_00229_4
crossref_primary_10_1038_s41598_020_73835_1
crossref_primary_10_3892_ol_2017_7532
crossref_primary_10_1016_j_tips_2019_09_005
crossref_primary_10_1016_j_trsl_2018_12_007
crossref_primary_10_1158_1541_7786_MCR_20_0687
crossref_primary_10_1016_j_jprot_2022_104485
crossref_primary_10_3892_ol_2020_11760
Cites_doi 10.1016/j.ccr.2014.02.025
10.1016/j.molcel.2009.04.034
10.1038/sj.onc.1210922
10.1111/cas.12225
10.1158/2159-8290.CD-13-0070
10.1126/science.1099314
10.1371/journal.pone.0052383
10.1016/S0014-4827(08)00404-7
10.1126/science.274.5295.2086
10.1016/j.febslet.2013.11.020
10.1172/JCI32278
10.1038/ncomms8679
10.1128/MCB.00375-09
10.1016/j.cell.2006.05.013
10.1073/pnas.0703854104
10.1016/j.febslet.2005.06.047
10.1016/j.cell.2006.05.028
10.1074/jbc.M102079200
10.1111/hel.12215
10.1038/cr.2014.99
10.1158/1078-0432.CCR-10-2200
10.1038/nrm3048
10.1016/j.phrs.2013.11.002
10.1038/nm.1966
10.1016/j.cell.2011.02.003
10.1111/j.1600-0854.2008.00788.x
10.1002/jcp.21635
10.1038/sj.onc.1203973
10.1016/j.cell.2009.04.025
10.1074/jbc.M111.264945
10.1073/pnas.1537685100
10.1242/jcs.083303
10.1056/NEJMoa040938
10.1016/j.cellsig.2005.03.026
10.1038/nrc2088
10.1038/nm.3388
10.1016/j.ctrv.2015.08.001
10.2217/pgs.14.133
ContentType Journal Article
Copyright The Author(s) 2016
Copyright Nature Publishing Group Aug 2016
Copyright © 2016, The Author(s) 2016 The Author(s)
Copyright_xml – notice: The Author(s) 2016
– notice: Copyright Nature Publishing Group Aug 2016
– notice: Copyright © 2016, The Author(s) 2016 The Author(s)
DBID C6C
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/srep31502
DatabaseName Springer_OA刊
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Science Database
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

MEDLINE
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 31502
ExternalDocumentID 10_1038_srep31502
27531070
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFPKN
CITATION
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c504t-8bb82588e8874a7744b11784fa1b510daeac0fde847790c23880573ac9c5beb23
IEDL.DBID RPM
ISSN 2045-2322
IngestDate Tue Sep 17 21:14:30 EDT 2024
Fri Oct 25 21:26:11 EDT 2024
Thu Oct 10 18:50:26 EDT 2024
Fri Aug 23 02:54:43 EDT 2024
Wed Oct 16 00:58:38 EDT 2024
Fri Oct 11 20:55:30 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c504t-8bb82588e8874a7744b11784fa1b510daeac0fde847790c23880573ac9c5beb23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987620/
PMID 27531070
PQID 1903381336
PQPubID 2041939
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4987620
proquest_miscellaneous_1812889434
proquest_journals_1903381336
crossref_primary_10_1038_srep31502
pubmed_primary_27531070
springer_journals_10_1038_srep31502
PublicationCentury 2000
PublicationDate 2016-08-17
PublicationDateYYYYMMDD 2016-08-17
PublicationDate_xml – month: 08
  year: 2016
  text: 2016-08-17
  day: 17
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2016
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Singh, Harris (CR3) 2005; 17
Zhang, Gureasko, Shen, Cole, Kuriyan (CR20) 2006; 125
Gilmartin (CR37) 2011; 17
Red Brewer (CR24) 2009; 34
Morris (CR29) 2013; 3
Sorkin, Goh (CR4) 2008; 314
Sun (CR32) 2011; 144
CR15
Galperin, Sorkin (CR30) 2008; 9
Zaidi (CR19) 2015; 20
Zhou (CR17) 2015; 6
Arteaga, Engelman (CR7) 2014; 25
Ozawa (CR28) 2012; 7
Vieira, Lamaze, Schmid (CR31) 1996; 274
Avraham, Yarden (CR5) 2011; 12
Sharma, Bell, Settleman, Haber (CR10) 2007; 7
Holbro (CR14) 2003; 100
Chong, Jänne (CR36) 2013; 19
Sebastian (CR1) 2006; 1766
Segatto, Anastasi, Alemà (CR35) 2011; 124
Zhou (CR39) 2014; 588
Roskoski (CR6) 2014; 79
Chung, Kim, Kim, Yim, Chock (CR38) 2011; 286
Nishimura (CR18) 2009; 29
Thiel, Carpenter (CR22) 2007; 104
Paez (CR9) 2004; 304
Zhu (CR33) 2007; 27
Jura (CR23) 2009; 137
Harari, Yarden (CR12) 2000; 19
Sato (CR25) 2013; 104
D’Amato (CR16) 2015; 41
Wang (CR34) 2014; 24
Hubbard (CR21) 2006; 125
Jin (CR27) 2009; 15
Lynch (CR8) 2004; 350
Dubská, Andera, Sheard (CR26) 2005; 579
Zhang (CR11) 2007; 117
Schneider, Wolf (CR2) 2009; 218
Hellyer, Kim, Koland (CR13) 2001; 276
24269963 - Pharmacol Res. 2014 Jan;79:34-74
12853564 - Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8933-8
19563760 - Cell. 2009 Jun 26;137(7):1293-307
11156523 - Oncogene. 2000 Dec 11;19(53):6102-14
21376233 - Cell. 2011 Mar 4;144(5):703-18
11546794 - J Biol Chem. 2001 Nov 9;276(45):42153-61
19560417 - Mol Cell. 2009 Jun 26;34(6):641-51
25704183 - Helicobacter. 2015 Oct;20(5):381-9
16023111 - FEBS Lett. 2005 Aug 1;579(19):4149-58
16777603 - Cell. 2006 Jun 16;125(6):1137-49
21705328 - J Biol Chem. 2011 Aug 26;286(34):29681-90
17318210 - Nat Rev Cancer. 2007 Mar;7(3):169-81
24202392 - Nat Med. 2013 Nov;19(11):1389-400
18793634 - Exp Cell Res. 2008 Oct 15;314(17):3093-106
8953040 - Science. 1996 Dec 20;274(5295):2086-9
19687304 - Mol Cell Biol. 2009 Oct;29(20):5529-39
21252999 - Nat Rev Mol Cell Biol. 2011 Feb;12(2):104-17
25712189 - Pharmacogenomics. 2015 ;16(3):257-71
19006176 - J Cell Physiol. 2009 Mar;218(3):460-6
23614898 - Cancer Discov. 2013 Jul;3(7):742-50
24651011 - Cancer Cell. 2014 Mar 17;25(3):282-303
18657070 - Traffic. 2008 Sep;9(10):1776-90
18042729 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19238-43
26158630 - Nat Commun. 2015 Jul 09;6:7679
19684583 - Nat Med. 2009 Sep;15(9):1088-92
21245089 - Clin Cancer Res. 2011 Mar 1;17(5):989-1000
15982853 - Cell Signal. 2005 Oct;17(10):1183-93
23300658 - PLoS One. 2012;7(12):e52383
17982484 - Oncogene. 2008 Apr 17;27(18):2525-31
23822636 - Cancer Sci. 2013 Oct;104(10):1315-22
15118073 - N Engl J Med. 2004 May 20;350(21):2129-39
24269888 - FEBS Lett. 2014 Jan 3;588(1):131-7
17671639 - J Clin Invest. 2007 Aug;117(8):2051-8
21576352 - J Cell Sci. 2011 Jun 1;124(Pt 11):1785-93
16889899 - Biochim Biophys Acta. 2006 Aug;1766(1):120-39
16777592 - Cell. 2006 Jun 16;125(6):1029-31
25081058 - Cell Res. 2014 Sep;24(9):1067-90
15118125 - Science. 2004 Jun 4;304(5676):1497-500
26276735 - Cancer Treat Rev. 2015 Dec;41(10):877-83
A Jin (BFsrep31502_CR27) 2009; 15
J-H Zhu (BFsrep31502_CR33) 2007; 27
A Sorkin (BFsrep31502_CR4) 2008; 314
N Jura (BFsrep31502_CR23) 2009; 137
T Holbro (BFsrep31502_CR14) 2003; 100
L Dubská (BFsrep31502_CR26) 2005; 579
JG Paez (BFsrep31502_CR9) 2004; 304
V D’Amato (BFsrep31502_CR16) 2015; 41
S Sebastian (BFsrep31502_CR1) 2006; 1766
H-M Wang (BFsrep31502_CR34) 2014; 24
X Zhang (BFsrep31502_CR20) 2006; 125
T Sun (BFsrep31502_CR32) 2011; 144
E Galperin (BFsrep31502_CR30) 2008; 9
D Harari (BFsrep31502_CR12) 2000; 19
NJ Hellyer (BFsrep31502_CR13) 2001; 276
MR Schneider (BFsrep31502_CR2) 2009; 218
R Avraham (BFsrep31502_CR5) 2011; 12
SF Zaidi (BFsrep31502_CR19) 2015; 20
SR Hubbard (BFsrep31502_CR21) 2006; 125
AB Singh (BFsrep31502_CR3) 2005; 17
M Red Brewer (BFsrep31502_CR24) 2009; 34
AG Gilmartin (BFsrep31502_CR37) 2011; 17
AV Vieira (BFsrep31502_CR31) 1996; 274
R Roskoski Jr. (BFsrep31502_CR6) 2014; 79
SV Sharma (BFsrep31502_CR10) 2007; 7
BFsrep31502_CR15
K Sato (BFsrep31502_CR25) 2013; 104
CL Arteaga (BFsrep31502_CR7) 2014; 25
YW Chung (BFsrep31502_CR38) 2011; 286
EJ Morris (BFsrep31502_CR29) 2013; 3
KW Thiel (BFsrep31502_CR22) 2007; 104
CR Chong (BFsrep31502_CR36) 2013; 19
H Zhang (BFsrep31502_CR11) 2007; 117
Y Zhou (BFsrep31502_CR17) 2015; 6
TJ Lynch (BFsrep31502_CR8) 2004; 350
M Nishimura (BFsrep31502_CR18) 2009; 29
T Ozawa (BFsrep31502_CR28) 2012; 7
Y Zhou (BFsrep31502_CR39) 2014; 588
O Segatto (BFsrep31502_CR35) 2011; 124
References_xml – volume: 25
  start-page: 282
  year: 2014
  end-page: 303
  ident: CR7
  article-title: ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.02.025
  contributor:
    fullname: Engelman
– volume: 34
  start-page: 641
  year: 2009
  end-page: 651
  ident: CR24
  article-title: The juxtamembrane region of the EGF receptor functions as an activation domain
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2009.04.034
  contributor:
    fullname: Red Brewer
– volume: 27
  start-page: 2525
  year: 2007
  end-page: 2531
  ident: CR33
  article-title: Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210922
  contributor:
    fullname: Zhu
– volume: 104
  start-page: 1315
  year: 2013
  end-page: 1322
  ident: CR25
  article-title: Inverse correlation between Thr-669 and constitutive tyrosine phosphorylation in the asymmetric epidermal growth factor receptor dimer conformation
  publication-title: Cancer Sci.
  doi: 10.1111/cas.12225
  contributor:
    fullname: Sato
– volume: 3
  start-page: 742
  year: 2013
  end-page: 750
  ident: CR29
  article-title: Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-13-0070
  contributor:
    fullname: Morris
– volume: 304
  start-page: 1497
  year: 2004
  end-page: 1500
  ident: CR9
  article-title: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
  publication-title: Science
  doi: 10.1126/science.1099314
  contributor:
    fullname: Paez
– volume: 7
  start-page: e52383
  year: 2012
  ident: CR28
  article-title: A Novel Rabbit Immunospot Array Assay on a Chip Allows for the Rapid Generation of Rabbit Monoclonal Antibodies with High Affinity
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0052383
  contributor:
    fullname: Ozawa
– volume: 314
  start-page: 3093
  year: 2008
  end-page: 3106
  ident: CR4
  article-title: Endocytosis and intracellular trafficking of ErbBs
  publication-title: Exp. Cell Res.
  doi: 10.1016/S0014-4827(08)00404-7
  contributor:
    fullname: Goh
– volume: 274
  start-page: 2086
  year: 1996
  end-page: 2089
  ident: CR31
  article-title: Control of EGF receptor signaling by clathrin-mediated endocytosis
  publication-title: Science
  doi: 10.1126/science.274.5295.2086
  contributor:
    fullname: Schmid
– volume: 588
  start-page: 131
  year: 2014
  end-page: 137
  ident: CR39
  article-title: p38-Mediated phosphorylation of Eps15 endocytic adaptor protein
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2013.11.020
  contributor:
    fullname: Zhou
– volume: 117
  start-page: 2051
  year: 2007
  end-page: 2058
  ident: CR11
  article-title: ErbB receptors: from oncogenes to targeted cancer therapies
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI32278
  contributor:
    fullname: Zhang
– volume: 6
  start-page: 7679
  year: 2015
  ident: CR17
  article-title: Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms8679
  contributor:
    fullname: Zhou
– volume: 29
  start-page: 5529
  year: 2009
  end-page: 5539
  ident: CR18
  article-title: TAK1-mediated serine/threonine phosphorylation of epidermal growth factor receptor via p38/extracellular signal-regulated kinase: NF-{kappa}B-independent survival pathways in tumor necrosis factor alpha signaling
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00375-09
  contributor:
    fullname: Nishimura
– volume: 125
  start-page: 1137
  year: 2006
  end-page: 1149
  ident: CR20
  article-title: An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
  publication-title: Cell
  doi: 10.1016/j.cell.2006.05.013
  contributor:
    fullname: Kuriyan
– volume: 104
  start-page: 19238
  year: 2007
  end-page: 19243
  ident: CR22
  article-title: Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0703854104
  contributor:
    fullname: Carpenter
– volume: 579
  start-page: 4149
  year: 2005
  end-page: 4158
  ident: CR26
  article-title: HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: an unexpected effect on TRAIL-induced apoptosis
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2005.06.047
  contributor:
    fullname: Sheard
– volume: 125
  start-page: 1029
  year: 2006
  end-page: 1031
  ident: CR21
  article-title: EGF receptor activation: push comes to shove
  publication-title: Cell
  doi: 10.1016/j.cell.2006.05.028
  contributor:
    fullname: Hubbard
– volume: 276
  start-page: 42153
  year: 2001
  end-page: 42161
  ident: CR13
  article-title: Heregulin-dependent Activation of Phosphoinositide 3-Kinase and Akt via the ErbB2/ErbB3 Co-receptor
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M102079200
  contributor:
    fullname: Koland
– ident: CR15
– volume: 20
  start-page: 381
  year: 2015
  end-page: 390
  ident: CR19
  article-title: Helicobacter pylori Induces Serine Phosphorylation of EGFR via Novel TAK1-p38 Activation Pathway in an HB-EGF-Independent Manner
  publication-title: Helicobacter
  doi: 10.1111/hel.12215
  contributor:
    fullname: Zaidi
– volume: 24
  start-page: 1067
  year: 2014
  end-page: 1090
  ident: CR34
  article-title: The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes
  publication-title: Cell Res
  doi: 10.1038/cr.2014.99
  contributor:
    fullname: Wang
– volume: 17
  start-page: 989
  year: 2011
  end-page: 1000
  ident: CR37
  article-title: GSK1120212 (JTP-74057) is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained Pathway Inhibition
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-2200
  contributor:
    fullname: Gilmartin
– volume: 12
  start-page: 104
  year: 2011
  end-page: 117
  ident: CR5
  article-title: Feedback regulation of EGFR signalling: decision making by early and delayed loops
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm3048
  contributor:
    fullname: Yarden
– volume: 1766
  start-page: 120
  year: 2006
  end-page: 139
  ident: CR1
  article-title: The complexity of targeting EGFR signalling in cancer: from expression to turnover
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Sebastian
– volume: 79
  start-page: 34
  year: 2014
  end-page: 74
  ident: CR6
  article-title: The ErbB/HER family of protein-tyrosine kinases and cancer
  publication-title: Pharmacological Research
  doi: 10.1016/j.phrs.2013.11.002
  contributor:
    fullname: Roskoski
– volume: 15
  start-page: 1088
  year: 2009
  end-page: 1092
  ident: CR27
  article-title: A rapid and efficient single-cell manipulation method for screening antigen-specific antibody–secreting cells from human peripheral blood
  publication-title: Nat. Med.
  doi: 10.1038/nm.1966
  contributor:
    fullname: Jin
– volume: 144
  start-page: 703
  year: 2011
  end-page: 718
  ident: CR32
  article-title: Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase
  publication-title: Cell
  doi: 10.1016/j.cell.2011.02.003
  contributor:
    fullname: Sun
– volume: 9
  start-page: 1776
  year: 2008
  end-page: 1790
  ident: CR30
  article-title: Endosomal Targeting of MEK2 Requires RAF, MEK Kinase Activity and Clathrin-Dependent Endocytosis
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2008.00788.x
  contributor:
    fullname: Sorkin
– volume: 218
  start-page: 460
  year: 2009
  end-page: 466
  ident: CR2
  article-title: The epidermal growth factor receptor ligands at a glance
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.21635
  contributor:
    fullname: Wolf
– volume: 19
  start-page: 6102
  year: 2000
  end-page: 6114
  ident: CR12
  article-title: Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203973
  contributor:
    fullname: Yarden
– volume: 137
  start-page: 1293
  year: 2009
  end-page: 1307
  ident: CR23
  article-title: Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment
  publication-title: Cell
  doi: 10.1016/j.cell.2009.04.025
  contributor:
    fullname: Jura
– volume: 286
  start-page: 29681
  year: 2011
  end-page: 29690
  ident: CR38
  article-title: Dual function of protein kinase C (PKC) in 12- -tetradecanoylphorbol-13-acetate (TPA)-induced manganese superoxide dismutase (MnSOD) expression: activation of CREB and FOXO3a by PKC-α phosphorylation and by PKC-mediated inactivation of Akt, respectively
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.264945
  contributor:
    fullname: Chock
– volume: 100
  start-page: 8933
  year: 2003
  end-page: 8938
  ident: CR14
  article-title: The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1537685100
  contributor:
    fullname: Holbro
– volume: 124
  start-page: 1785
  year: 2011
  end-page: 1793
  ident: CR35
  article-title: Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors
  publication-title: J. Cell. Sci.
  doi: 10.1242/jcs.083303
  contributor:
    fullname: Alemà
– volume: 350
  start-page: 2129
  year: 2004
  end-page: 2139
  ident: CR8
  article-title: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa040938
  contributor:
    fullname: Lynch
– volume: 17
  start-page: 1183
  year: 2005
  end-page: 1193
  ident: CR3
  article-title: Autocrine, paracrine and juxtacrine signaling by EGFR ligands
  publication-title: Cell. Signal.
  doi: 10.1016/j.cellsig.2005.03.026
  contributor:
    fullname: Harris
– volume: 7
  start-page: 169
  year: 2007
  end-page: 181
  ident: CR10
  article-title: Epidermal growth factor receptor mutations in lung cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2088
  contributor:
    fullname: Haber
– volume: 19
  start-page: 1389
  year: 2013
  end-page: 1400
  ident: CR36
  article-title: The quest to overcome resistance to EGFR-targeted therapies in cancer
  publication-title: Nat. Med.
  doi: 10.1038/nm.3388
  contributor:
    fullname: Jänne
– volume: 41
  start-page: 877
  year: 2015
  end-page: 883
  ident: CR16
  article-title: Mechanisms of lapatinib resistance in HER2-driven breast cancer
  publication-title: Cancer Treatment Reviews
  doi: 10.1016/j.ctrv.2015.08.001
  contributor:
    fullname: D’Amato
– volume: 124
  start-page: 1785
  year: 2011
  ident: BFsrep31502_CR35
  publication-title: J. Cell. Sci.
  doi: 10.1242/jcs.083303
  contributor:
    fullname: O Segatto
– volume: 20
  start-page: 381
  year: 2015
  ident: BFsrep31502_CR19
  publication-title: Helicobacter
  doi: 10.1111/hel.12215
  contributor:
    fullname: SF Zaidi
– volume: 7
  start-page: 169
  year: 2007
  ident: BFsrep31502_CR10
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2088
  contributor:
    fullname: SV Sharma
– volume: 104
  start-page: 19238
  year: 2007
  ident: BFsrep31502_CR22
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0703854104
  contributor:
    fullname: KW Thiel
– volume: 274
  start-page: 2086
  year: 1996
  ident: BFsrep31502_CR31
  publication-title: Science
  doi: 10.1126/science.274.5295.2086
  contributor:
    fullname: AV Vieira
– volume: 579
  start-page: 4149
  year: 2005
  ident: BFsrep31502_CR26
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2005.06.047
  contributor:
    fullname: L Dubská
– volume: 17
  start-page: 1183
  year: 2005
  ident: BFsrep31502_CR3
  publication-title: Cell. Signal.
  doi: 10.1016/j.cellsig.2005.03.026
  contributor:
    fullname: AB Singh
– volume: 276
  start-page: 42153
  year: 2001
  ident: BFsrep31502_CR13
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M102079200
  contributor:
    fullname: NJ Hellyer
– volume: 27
  start-page: 2525
  year: 2007
  ident: BFsrep31502_CR33
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210922
  contributor:
    fullname: J-H Zhu
– volume: 1766
  start-page: 120
  year: 2006
  ident: BFsrep31502_CR1
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: S Sebastian
– volume: 15
  start-page: 1088
  year: 2009
  ident: BFsrep31502_CR27
  publication-title: Nat. Med.
  doi: 10.1038/nm.1966
  contributor:
    fullname: A Jin
– volume: 6
  start-page: 7679
  year: 2015
  ident: BFsrep31502_CR17
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms8679
  contributor:
    fullname: Y Zhou
– volume: 7
  start-page: e52383
  year: 2012
  ident: BFsrep31502_CR28
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0052383
  contributor:
    fullname: T Ozawa
– volume: 29
  start-page: 5529
  year: 2009
  ident: BFsrep31502_CR18
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00375-09
  contributor:
    fullname: M Nishimura
– ident: BFsrep31502_CR15
  doi: 10.2217/pgs.14.133
– volume: 17
  start-page: 989
  year: 2011
  ident: BFsrep31502_CR37
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-2200
  contributor:
    fullname: AG Gilmartin
– volume: 19
  start-page: 1389
  year: 2013
  ident: BFsrep31502_CR36
  publication-title: Nat. Med.
  doi: 10.1038/nm.3388
  contributor:
    fullname: CR Chong
– volume: 79
  start-page: 34
  year: 2014
  ident: BFsrep31502_CR6
  publication-title: Pharmacological Research
  doi: 10.1016/j.phrs.2013.11.002
  contributor:
    fullname: R Roskoski Jr.
– volume: 314
  start-page: 3093
  year: 2008
  ident: BFsrep31502_CR4
  publication-title: Exp. Cell Res.
  doi: 10.1016/S0014-4827(08)00404-7
  contributor:
    fullname: A Sorkin
– volume: 100
  start-page: 8933
  year: 2003
  ident: BFsrep31502_CR14
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1537685100
  contributor:
    fullname: T Holbro
– volume: 144
  start-page: 703
  year: 2011
  ident: BFsrep31502_CR32
  publication-title: Cell
  doi: 10.1016/j.cell.2011.02.003
  contributor:
    fullname: T Sun
– volume: 588
  start-page: 131
  year: 2014
  ident: BFsrep31502_CR39
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2013.11.020
  contributor:
    fullname: Y Zhou
– volume: 25
  start-page: 282
  year: 2014
  ident: BFsrep31502_CR7
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.02.025
  contributor:
    fullname: CL Arteaga
– volume: 304
  start-page: 1497
  year: 2004
  ident: BFsrep31502_CR9
  publication-title: Science
  doi: 10.1126/science.1099314
  contributor:
    fullname: JG Paez
– volume: 19
  start-page: 6102
  year: 2000
  ident: BFsrep31502_CR12
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203973
  contributor:
    fullname: D Harari
– volume: 12
  start-page: 104
  year: 2011
  ident: BFsrep31502_CR5
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm3048
  contributor:
    fullname: R Avraham
– volume: 41
  start-page: 877
  year: 2015
  ident: BFsrep31502_CR16
  publication-title: Cancer Treatment Reviews
  doi: 10.1016/j.ctrv.2015.08.001
  contributor:
    fullname: V D’Amato
– volume: 104
  start-page: 1315
  year: 2013
  ident: BFsrep31502_CR25
  publication-title: Cancer Sci.
  doi: 10.1111/cas.12225
  contributor:
    fullname: K Sato
– volume: 218
  start-page: 460
  year: 2009
  ident: BFsrep31502_CR2
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.21635
  contributor:
    fullname: MR Schneider
– volume: 137
  start-page: 1293
  year: 2009
  ident: BFsrep31502_CR23
  publication-title: Cell
  doi: 10.1016/j.cell.2009.04.025
  contributor:
    fullname: N Jura
– volume: 117
  start-page: 2051
  year: 2007
  ident: BFsrep31502_CR11
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI32278
  contributor:
    fullname: H Zhang
– volume: 24
  start-page: 1067
  year: 2014
  ident: BFsrep31502_CR34
  publication-title: Cell Res
  doi: 10.1038/cr.2014.99
  contributor:
    fullname: H-M Wang
– volume: 125
  start-page: 1029
  year: 2006
  ident: BFsrep31502_CR21
  publication-title: Cell
  doi: 10.1016/j.cell.2006.05.028
  contributor:
    fullname: SR Hubbard
– volume: 9
  start-page: 1776
  year: 2008
  ident: BFsrep31502_CR30
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2008.00788.x
  contributor:
    fullname: E Galperin
– volume: 286
  start-page: 29681
  year: 2011
  ident: BFsrep31502_CR38
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.264945
  contributor:
    fullname: YW Chung
– volume: 350
  start-page: 2129
  year: 2004
  ident: BFsrep31502_CR8
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa040938
  contributor:
    fullname: TJ Lynch
– volume: 3
  start-page: 742
  year: 2013
  ident: BFsrep31502_CR29
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-13-0070
  contributor:
    fullname: EJ Morris
– volume: 34
  start-page: 641
  year: 2009
  ident: BFsrep31502_CR24
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2009.04.034
  contributor:
    fullname: M Red Brewer
– volume: 125
  start-page: 1137
  year: 2006
  ident: BFsrep31502_CR20
  publication-title: Cell
  doi: 10.1016/j.cell.2006.05.013
  contributor:
    fullname: X Zhang
SSID ssj0000529419
Score 2.3267584
Snippet Tyrosine kinase activity of the asymmetric EGFR homodimer is negatively regulated via ERK-mediated phosphorylation of Thr-669 in the juxtamembrane domain. In...
Abstract Tyrosine kinase activity of the asymmetric EGFR homodimer is negatively regulated via ERK-mediated phosphorylation of Thr-669 in the juxtamembrane...
SourceID pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 31502
SubjectTerms 631/67/395
631/80/86/2368
96/95
Alanine
Breast cancer
Breast Neoplasms - enzymology
Breast Neoplasms - genetics
Breast Neoplasms - pathology
Cell Line, Tumor
Epidermal growth factor receptors
ErbB protein
ErbB-2 protein
ErbB-3 protein
Extracellular signal-regulated kinase
Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors
Extracellular Signal-Regulated MAP Kinases - genetics
Extracellular Signal-Regulated MAP Kinases - metabolism
Feedback inhibition
Female
HEK293 Cells
Humanities and Social Sciences
Humans
Kinases
Metabolic pathways
Monoclonal antibodies
multidisciplinary
Multienzyme Complexes - genetics
Multienzyme Complexes - metabolism
Phosphorylation
Phosphorylation - genetics
Protein Domains
Protein-tyrosine kinase
Receptor, ErbB-2 - genetics
Receptor, ErbB-2 - metabolism
Receptor, ErbB-3 - genetics
Receptor, ErbB-3 - metabolism
Science
Threonine
Threonine - genetics
Threonine - metabolism
SummonAdditionalLinks – databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVkhcEO8uLcg8rlETx0mcE6JoVxWIClVU6i3yK-qCNtnuZhH99_2cF2wrccghsa04Hnvmm0dmiD6koU4d5zqIbJIFwso80LkDM0xNxkuIsMh4g_630_TkXHy5SC56g9umD6sceGLLqG1tvI38CIIL2hQ0qvTj6irwVaO8d7UvoXGf9rjP3DShvePZ6fez0cri_VgiyoeUQrE8guBZxUBBfFcQ3UGXd4Mkb3lKWwE0f0yPeuTIPnWkfkL3XPWUHnS1JK-fUT2HHNLK_GJ99DmrSzZb62POfi8Um519Ddq_RIAw2eqy3uBaX3eBcL6n8sO8hRbNDejrrbSOLSrcOPZz-6dRS7eEZo2Htl6qRfWczuezH59Pgr6aQmCSUDSB1BraoJQObEUooD6hoyiTolSRxsG0Ciw4LK2DuMry0HCfJSbJYmVyk2jo3_ELmlR15faJuViVViXGgpDCRqESKTfcCctVkkojpvRuWNpi1SXNKFpndyyLcf2ndDgsetGfm03xl8pTejs2Y8d7NwY-sd6iDzCJ9Gnj8Z6XHY3Gt3BoX1BowyllO9QbO_hs2rst1eKyzaotci8YMPL9QOd_pnV78q_-P_kDeghglXrbc5Qd0qRZb91rgJdGv-l36A0GD_Lg
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwELYQVSUuFaVAFygyj2sgcZzEOVQVVLtCreCAWIlb5FfEtmyyLFnE_vt-zmPFQg8cckhsy86MPfPN2J4h5Dj2VWwZU15gosTjRqSeSi2EYawTlkOFBdo59C-v4osh_3Ub3a6QLsdmS8DH_5p2Lp_UcHp_8vww_4EF_725Mi5OoUsmIYANJPEHxsPQTe7LFuU3Ib5ZyoO0iyv0ssWyNnoDMd-elHy1XVprocE6-dTCR3rW8PszWbHFBvnYJJScfyHlAMpISf2XtkfQaZnT_lSdM_o0krR__durr4oAZtLJXfmIZzpvTsO5mtI1c25aFFdgsnPVWjoq8GLpn9lzJcd2DPMaH005lqNikwwH_ZufF16bUsHTkc8rTygFk1AIC9nCJaAfV0GQCJ7LQGF1Ggk57OfGQmclqa-ZCxUTJaHUqY4UjPBwi6wWZWG_EmpDmRsZaQNuchP4ksdMM8sNk1EsNO-Rw4602aSJnJHVO96hyBb075G9juhZx_sMGAWGM4znuEcOFsWY9m4vA79YzlAHwES42PHoZ7vh0aIXBhMMVq3fI8kS9xYVXEjt5ZJidFeH1uap0w5oedTx-cWwXg9-5x2j2yVrgFix80IHyR5ZraYz-w0wplL79ST9B-hL9as
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer_OA刊
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwELYQqFIvVemDboHKQK8RseM4zhHQrlCr9oBA4hb5FbGgTVZLFsG_53OyiVi4cMgh8Vh2PPbMNzP2mJDfMjbSc24i5tIsEk7lkck9hKG0GS-hwpgNDv1__-X5lfhznV5vkIP-LMxa_D5Rx9AT8wSgBVJ2K2XQziEeK88GN0oIVAmW9zmDXtZY1zRv4OPbXZCvQqGthpl8Jp9W0JCedLzcJhu--kI-dJdFPn0l9QSKxmh7R1fby2ld0vHCnHL6MNV0fPE3ao-BAELS-U19j2fx1O10C5Q6VAsuWBQ3YGBww3o6rfDi6e3ysdEzP4PpjI-unulp9Y1cTcaXZ-fR6rqEyKaxaCJlDMw9pTzkhtCAdcIwlilRamaw8pyGjI1L56GPsjy2PKSBSbNE29ymBgZ28p1sVnXlfxDqE106nVoHTgnHYi0kt9wLx3UqlRUjctgPbTHvsmIUbTQ7UcUw_iOy1w96sVoY9wXwB4xiGMZyRA6GYkzpEKfAL9ZL0AB0qJAXHu3sdDwaWuEwr2CxxiOSrXFvIAjpstdLqulNmzZb5EHyo-ZRz-cX3Xrd-Z_votolHwGgZPAxs2yPbDaLpd8HSGnMr3aaPgOr4ueI
  priority: 102
  providerName: Springer Nature
Title Feedback control of ErbB2 via ERK-mediated phosphorylation of a conserved threonine in the juxtamembrane domain
URI https://link.springer.com/article/10.1038/srep31502
https://www.ncbi.nlm.nih.gov/pubmed/27531070
https://www.proquest.com/docview/1903381336
https://search.proquest.com/docview/1812889434
https://pubmed.ncbi.nlm.nih.gov/PMC4987620
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SlEIvpe-6TRf1cXXWlmVJPjbLLqFlQwgN7M3oZeK2tpeNtzT_viM_lmxy68EGWbIla0aab0ajEcAXHmnuKNVhbFMRMiuzUGcOJ0NuBC1QhMXGG_SX5_zsin1bpasDSMe9MJ3TvtHlSf27OqnL6863cl2Z6egnNr1Yzljmx3A0PYRDkSR3VPQ-oDfNWJyNUYQSOUVZs04Q-PiTayjCc9R4on0x9ABbPnSRvLdO2omfxTN4OuBG8rVv33M4cPULeNyfJHn7EpoFSiGtzC8y-J6TpiDzjT6l5E-pyPzye9jtEUF8SdbXzQ1em9veDc6XVP41b5_F7Bap6220jpQ1Jhz5uf3bqspVqFfjQ9tUqqxfwdVi_mN2Fg5nKYQmjVgbSq1RF5TS4aTCFGI-puNYSFaoWOOwtAon4KiwDoWVyCJDfYyYVCTKZCbVqH0nr-Gobmr3FohLVGFVaiySkdk4UoxTQx2zVKVcGhbAp7Fr83UfMiPvlroTme9IEcDx2On5MGpucgQnqDGj1swD-LjLRn73ixj4i80WyyAikT5oPNbzpqfRrpaRuAGIPertCvhY2vs5yGJdTO2BpQL4PNL5TrPuN_7df3__PTxBxMW9UToWx3DUbrbuA6KaVk-Ql1diAo9O5-cXl5ia8dmksxDgfcnkpOPyf-6K_6s
link.rule.ids 230,315,733,786,790,870,891,12077,21409,24339,27946,27947,31743,31744,33768,33769,41144,42213,43334,43829,51600,53816,53818,74091,74648
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB5RqqpcUN9sS6lLe41IbCd2TlVb7WopjwMCaW-RXxFbtMmym63g33ecFyxIHHJIbCuOx5755pEZgO9JqBNHqQ4iG4uAW5kGOnXIDBMjaI4iLDLeoH9ymowv-J9JPGkNbss2rLLjiTWjtqXxNvIDFFyoTaFGlfyYXwe-apT3rrYlNJ7Bc84Y87nzxUT0NhbvxeJR2iUUYvIAxc6cIQai62LoEbZ8HCL5wE9ai5_RK9hucSP52RD6NWy44g28aCpJ3r6FcoRSSCtzRdrYc1LmZLjQvyj5N1VkeHYU1P-IIL4k88tyidfitgmD8z2VH-bts9hcIXW9jdaRaYE3jvxd3VRq5maoV-NDW87UtHgHF6Ph-e9x0NZSCEwc8iqQWqMuKKVDpsIVYj6uo0hInqtI47G0ChlwmFuHwkqkoaE-R0wsmDKpiTVq3-w9bBZl4XaAOKZyq2JjkYzcRqHiCTXUcUtVnEjDB7DfLW02b1JmZLWrm8msX_8B7HaLnrWnZpnd0XgAX_tm3O_eiYGfWK6wDyIS6ZPG43s-NDTq30JR90J1NhyAWKNe38Hn0l5vKaaXdU5tnnqxgCO_dXS-N62Hk__49OS_wMvx-clxdnx4evQJthBiJd4KHYld2KwWK_cZYUyl9-q9-h92_PRl
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgCMQL4jo6NjCX16iJ48TO0zRGq8FgQohJfYt8i1ZQk65NEfv3fM4Nukk85CGxrTg-9vnOLecQ8i4NdeoY00FkExFwK7NAZw7MMDWCFYCwyHiD_pez9OScf5olsy7-ad2FVfY8sWHUtjLeRj4GcEGbgkaVjosuLOLrh-nh8jLwFaS8p7Urp3Gb3BFQWvwhFTMx2Fu8R4tHWZ9cKJZjQNAyhjzEtiHphpx5M1zyms-0gaLpQ_KgkyHpUUv0R-SWKx-Tu21VyasnpJoCkbQyP2kXh06rgk5W-j2jv-aKTr6dBs3_IpA16fKiWuNaXbUhcb6n8sO8rRbNNSjt7bWOzkvcOPpj87tWC7eAjo2HtlqoefmUnE8n349Pgq6uQmCSkNeB1Bp6oZQODIYryH9cR5GQvFCRxhG1Csw4LKwDcIksNMzni0lErExmEg1NPH5GdsqqdM8JdbEqrEqMBUm5jULFU2aY45apJJWGj8ibfmnzZZs-I2_c3rHMh_Ufkf1-0fPuBK3zv_QekddDM_a-d2jgE6sN-kA6kT6BPN6z29JoeAuDHgbVNhwRsUW9oYPPq73dUs4vmvzaPPMQgZFvezr_M63rk9_7_-RfkXvYpvnnj2enL8h9SFupN0hHYp_s1KuNO4BEU-uXzVb9A6eN-Jo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Feedback+control+of+ErbB2+via+ERK-mediated+phosphorylation+of+a+conserved+threonine+in+the+juxtamembrane+domain&rft.jtitle=Scientific+reports&rft.au=Kawasaki%2C+Yuki&rft.au=Sakimura%2C+Ayaka&rft.au=Park%2C+Chul+Min&rft.au=Tomaru%2C+Rika&rft.date=2016-08-17&rft.eissn=2045-2322&rft.volume=6&rft.spage=31502&rft.epage=31502&rft_id=info:doi/10.1038%2Fsrep31502&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon